OBJECTIVE: To quantify the value of performing active surveillance cultures for detection of methicillin-resistant Staphylococcus aureus (MRSA) on intensive care unit (ICU) discharge. DESIGN: Prospective cohort study. SETTING: Medical ICU (MICU) and surgical ICU (SICU) of a tertiary care hospital. PARTICIPANTS: We analyzed data on adult patients who were admitted to the MICU or SICU between January 17, 2001, and December 31, 2004. All participants had a length of ICU stay of at least 48 hours and had surveillance cultures of anterior nares specimens performed on ICU admission and discharge. Patients who had MRSA-positive clinical cultures in the ICU were excluded. RESULTS: Of 2,918 eligible patients, 178 (6%) were colonized with MRSA on ICU admission, and 65 (2%) acquired MRSA in the ICU and were identified by results of discharge surveillance cultures. Patients with MRSA colonization confirmed by results of discharge cultures spent 853 days in non-ICU wards after ICU discharge, which represented 27% of the total number of MRSA colonization-days during hospitalization in non-ICU wards for patients discharged from the ICU. CONCLUSIONS: Surveillance cultures of nares specimens collected at ICU discharge identified a large percentage of MRSA-colonized patients who would not have been identified on the basis of results of clinical cultures or admission surveillance cultures alone. Furthermore, these patients were responsible for a large percentage of the total number of MRSA colonization-days during hospitalization in non-ICU wards for patients discharged from the ICU.
OBJECTIVE: To quantify the value of performing active surveillance cultures for detection of methicillin-resistant Staphylococcus aureus (MRSA) on intensive care unit (ICU) discharge. DESIGN: Prospective cohort study. SETTING: Medical ICU (MICU) and surgical ICU (SICU) of a tertiary care hospital. PARTICIPANTS: We analyzed data on adult patients who were admitted to the MICU or SICU between January 17, 2001, and December 31, 2004. All participants had a length of ICU stay of at least 48 hours and had surveillance cultures of anterior nares specimens performed on ICU admission and discharge. Patients who had MRSA-positive clinical cultures in the ICU were excluded. RESULTS: Of 2,918 eligible patients, 178 (6%) were colonized with MRSA on ICU admission, and 65 (2%) acquired MRSA in the ICU and were identified by results of discharge surveillance cultures. Patients with MRSA colonization confirmed by results of discharge cultures spent 853 days in non-ICU wards after ICU discharge, which represented 27% of the total number of MRSA colonization-days during hospitalization in non-ICU wards for patients discharged from the ICU. CONCLUSIONS: Surveillance cultures of nares specimens collected at ICU discharge identified a large percentage of MRSA-colonized patients who would not have been identified on the basis of results of clinical cultures or admission surveillance cultures alone. Furthermore, these patients were responsible for a large percentage of the total number of MRSA colonization-days during hospitalization in non-ICU wards for patients discharged from the ICU.
Authors: Marin L Schweizer; Jon P Furuno; George Sakoulas; J Kristie Johnson; Anthony D Harris; Michelle D Shardell; Jessina C McGregor; Kerri A Thom; Eli N Perencevich Journal: Antimicrob Agents Chemother Date: 2010-12-20 Impact factor: 5.191
Authors: Marin L Schweizer; Michael R Eber; Ramanan Laxminarayan; Jon P Furuno; Kyle J Popovich; Bala Hota; Michael A Rubin; Eli N Perencevich Journal: Infect Control Hosp Epidemiol Date: 2011-02 Impact factor: 3.254
Authors: Hannah R Day; Eli N Perencevich; Anthony D Harris; Ann L Gruber-Baldini; Seth S Himelhoch; Clayton H Brown; Emily Dotter; Daniel J Morgan Journal: Infect Control Hosp Epidemiol Date: 2011-12-07 Impact factor: 3.254
Authors: Marin L Schweizer; Jon P Furuno; Anthony D Harris; J Kristie Johnson; Michelle D Shardell; Jessina C McGregor; Kerri A Thom; George Sakoulas; Eli N Perencevich Journal: PLoS One Date: 2010-07-02 Impact factor: 3.240
Authors: R Scott Evans; Carrie Jane Wallace; James F Lloyd; Caroline W Taylor; Rouett H Abouzelof; Sharon Sumner; Kyle V Johnson; Amyanne Wuthrich; Stephan Harbarth; Matthew H Samore Journal: J Am Med Inform Assoc Date: 2008-04-24 Impact factor: 4.497
Authors: Daniel J Morgan; Hannah R Day; Jon P Furuno; Atlisa Young; J Kristie Johnson; Douglas D Bradham; Eli N Perencevich Journal: Infect Control Hosp Epidemiol Date: 2010-10-28 Impact factor: 3.254
Authors: Carley B Emerson; Lindsay M Eyzaguirre; Jennifer S Albrecht; Angela C Comer; Anthony D Harris; Jon P Furuno Journal: Infect Control Hosp Epidemiol Date: 2012-04-16 Impact factor: 3.254